Effects on mortality of early vs late administration of convalescent plasma in the treatment of Covid-19

The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first seen in the city of Wuhan, China, in December 2019 and then spread worldwide. On 24 March 2020, the U.S. Food and Drug Administration reported that the use of convalescent plasma (CP) containing antibodies against...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Transfus Apher Sci
Egile Nagusiak: Kocayiğit, Havva, Demir, Gürkan, Karacan, Alper, Süner, Kezban Özmen, Tomak, Yakup, Yaylacı, Selçuk, Dheir, Hamad, Kalpakci, Yasin, Erdem, Ali Fuat
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier Ltd. 2021
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8064905/
https://ncbi.nlm.nih.gov/pubmed/33962885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.transci.2021.103148
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak